2019 Annual Meeting | C5 - What Do I Do Now?: Neurologic Consultations in Cancer Patients I

Date Saturday 05/04/19

Time 07:00 AM - 09:00 AM EDT Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Jaishri Blakeley, MD, FAAN

Topic(s) Neuro-oncology

Learning Objectives Participants should be aware of the evidence available to guide management of neurologic complications of systemic cancers. They will also recognize systemic toxicities of brain cancer therapy, the neurologic toxicities of drugs used in transplantation, efficiently evaluate patients for CNS infections, and screen for neurologic treatment sequelae in long-term cancer survivors.

CME Available 2.00 CME credits

Core Competencies Patient Care & Procedural Skills, Interpersonal and Communication Skills, Professionalism, Medical Knowledge, Practice-based Learning and Improvement, Systems-based Practice

Program Level Intermediate

Recommended Audience Fellow, Resident, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider, Neurohospitalist, Medical Student

Teaching Styles Case-based, Didactic, Audience Participation

Program Materials Program Evaluations

Event Timeline
07:05 AM - 07:35 AM EDT	Speaker	Management of Medical Complications of Brain Cancer Jaishri Blakeley, MD, FAAN
07:35 AM - 08:05 AM EDT	Speaker	Neurologic Complications of Systemic Cancers Maciej M. Mrugala, MD, PhD, MPH, FAAN
08:10 AM - 09:00 AM EDT	Speaker	Bringing It All Together: Addressing Real World Neurology Consults Amy A. Pruitt, MD, FAAN

Faculty Disclosures
Jaishri Blakeley, MD, FAAN	Dr. Blakeley has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Springworks Therapeutics.
Amy A. Pruitt, MD, FAAN	Dr. Pruitt has nothing to disclose.
Maciej M. Mrugala, MD, PhD, MPH, FAAN	Dr. Mrugala has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Veevo Biomedicines Inc. Dr. Mrugala has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arbor Pharmaceuticals. Dr. Mrugala has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astra-Zeneca. Dr. Mrugala has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Mrugala has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kyiatec . The institution of Dr. Mrugala has received research support from Arbor Pharmaceuticals. Dr. Mrugala has a non-compensated relationship as a Program Director with Society for Neuro-Oncology that is relevant to AAN interests or activities.

��ɫ��

��ɫ��